CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) EBITDA (2013 - 2025)

Updated

CNBX Pharmaceuticals (CNBX) posted EBITDA of -$64,002 for fiscal Q1 2026 (quarter ended Nov 30, 2025), compared with -$36,837 a year earlier.

Analysis

CNBX Pharmaceuticals Inc. (CNBX) EBITDA (2013 - 2025) Analysis & Trends

For the trailing twelve months through Nov 30, 2025, EBITDA at CNBX Pharmaceuticals was -$298,856; for FY2025 (ended Aug 31, 2025), it was -$271,691.

  • In prior fiscal years, CNBX Pharmaceuticals' EBITDA was -$510,819 in FY2024, -$769,319 in FY2023, -$2.76 million in FY2022 and -$2.38 million in FY2021.
  • Quarterly EBITDA has run from a low of -$1.06 million in fiscal Q1 2022 to a high of -$36,837 in fiscal Q1 2025 over five years.
  • According to Business Quant data, EBITDA for the three prior fiscal quarters was -$129,731 (Q4 2025), -$40,380 (Q3 2025) and -$64,743 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2025 -64,002.00
Aug 31, 2025 -129,731.00
May 31, 2025 -40,380.00
Feb 28, 2025 -64,743.00
Nov 30, 2024 -36,837.00
Aug 31, 2024 -52,533.00
May 31, 2024 -152,278.00
Feb 29, 2024 -173,569.00
Nov 30, 2023 -132,439.00
Aug 31, 2023 -123,007.00
May 31, 2023 -133,088.00
Feb 28, 2023 -209,620.00
Nov 30, 2022 -303,605.00
Aug 31, 2022 -431,065.00
May 31, 2022 -586,178.00
Feb 28, 2022 -679,673.00
Nov 30, 2021 -1.06 Mn
Aug 31, 2021 -545,351.00
May 31, 2021 -620,306.00
Feb 28, 2021 -611,367.00
API Access

CNBX Pharmaceuticals Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CNBX&period=max&api_key=YOUR_API_KEY